Acquired Blue Nevi in Older Individuals Retrospective Case Series from a Veterans Affairs Population, 1991 to 2013
Total Page:16
File Type:pdf, Size:1020Kb
Research Case Report/Case Series Acquired Blue Nevi in Older Individuals Retrospective Case Series From a Veterans Affairs Population, 1991 to 2013 Erik S. Cabral, MD; Frank W. Chen, BA; Barbara M. Egbert, MD; Susan M. Swetter, MD IMPORTANCE Apart from the atypical mole phenotype, development of new melanocytic nevi in older individuals is uncommon and considered worrisome for melanoma. We performed a retrospective case series in a Veterans Affairs population from 1991 to 2013 to characterize blue nevi (BN) by patient age at biopsy, location, self-reported duration, and relation to prior or subsequent development of cutaneous melanoma. Author Affiliations: Department of OBSERVATIONS A total of 204 BN were identified in 194 predominantly male patients Dermatology, Veterans Affairs Palo (90.7%) who had a mean (SD) age of 62.8 (14.4) years. Clinical duration of 10 years or less Alto Health Care System, Palo Alto, California (Cabral, Swetter); was reported by 90.3% of patients with available data (32.0%). Histopathologic examination Department of Pathology Services, classified 74.0% of BN as common, 1.5% as cellular, and 24.5% as combined type. No Veterans Affairs Palo Alto Health Care malignant BN were identified; however, 18 primary melanomas were diagnosed, most System, Palo Alto, California (Egbert); Department of Dermatology, (72.2%) prior to blue nevus biopsy, including 38.9% in situ and 61.1% with mean (SD) Breslow Pigmented Lesion and Melanoma thickness of 1.02 (0.99) mm. Program, Stanford University Medical Center, Stanford, California (Cabral, CONCLUSIONS AND RELEVANCE The later patient-reported onset of BN suggests a potential Chen, Egbert, Swetter); Bennett Surgical Center, Santa Monica, alternative mechanism of nevogenesis compared with common acquired nevi and differs California (Cabral). from prior reports of BN development in younger adults. The lack of association with Corresponding Author: Susan M. melanoma in older individuals suggests that most benign-appearing BN may be safely Swetter, MD, Department of observed, even in a cohort at higher risk for skin cancer. Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center, 900 Blake JAMA Dermatol. 2014;150(8):873-876. doi:10.1001/jamadermatol.2013.7366 Wilbur Dr, W0103, Stanford, CA Published online April 30, 2014. 94305-5356 ([email protected]). lue nevi (BN) are benign pigmented lesions with rare ment alteration, to malignant entities, such as pigmented basal malignant potential. They are considered a subset of cell carcinoma or melanoma. B dermal dendritic melanocytic proliferations, which de- Apart from the setting of the atypical mole or dysplastic rive their dark blue or bluish black color from the scattering nevi syndrome, development of new melanocytic nevi after of light by dermal melanin, known as the Tyndall effect.1,2 The age 50 years is uncommon and raises concern about the diag- melanocytes in BN typically stain positive for Human Mela- nosis of cutaneous melanoma. Based on our clinical observa- noma Black-45 (HMB-45), suggesting that BN stem from la- tion of the increased frequency and later onset of BN in a pre- tent dendritic melanocytes trapped in the dermal layer dur- dominantly elderly population, we sought to characterize BN ing their migration from the neural crest to the epidermis.3 clinically and histopathologically to elucidate patient- There are 3 main histologic subtypes of BN: common (includ- reported age of onset, the relationship to prior, concomitant, ing sclerotic type), combined, and cellular. Common BN gen- or subsequent primary melanoma, and their malignant po- erally present as solitary and small (1-5 mm) dark blue mac- tential, including the proportion of cases identified as malig- ules or dome-shaped papules. Blue nevi are also commonly nant BN or blue nevus–like melanoma. observed as part of combined nevi, most often in conjunc- tion with a compound or intradermal nevus, and less fre- quently, with a Spitz or dysplastic nevus. Cellular BN are more Report of Cases likely than common BN to be elevated, larger in size, and have greater malignant potential.1 A retrospective review of BN identified from 1991 to 2013 Patients may report BN as an aesthetic concern because in the Veterans Affairs Palo Alto Health Care System they are often mistaken for cosmetic or traumatic tattoos. For (VAPAHCS) Pathology Service database was performed, the clinician, the differential diagnosis ranges from benign en- with clinical chart review to determine patient outcome, tities, such as common nevi, tattoo, or postinflammatory pig- reported duration of the lesion, and other clinical character- jamadermatology.com JAMA Dermatology August 2014 Volume 150, Number 8 873 Copyright 2014 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/28/2021 Research Case Report/Case Series Acquired Blue Nevi in Older Individuals istics. The VAPAHCS electronic medical record did not A total of 204 cases of biopsy-proven BN were identified become widely available until 1997, thereby limiting clinical in 194 patients who had a mean (SD) age of 62.8 (14.4) years, data annotation for 33 patients. Clinical outcome data were with most biopsies being performed to exclude the diagno- assessed through May 30, 2013. The study was approved by sis of melanoma based on patient report of short or Stanford University and VAPAHCS institutional review unknown duration of the lesion. Patients were predomi- boards. nantly male (90.7%) and white, typical of the VAPAHCS population, although race/ethnicity was not noted in all cases. The mean duration of patient follow-up was 9.0 years Table 1. Clinical and Histopathological Characteristics of 204 Blue Nevi in 194 Patients (range, 0-22 years). In terms of histologic subtypes, 151 of 204 BN (74.0%) Characteristic No. (%) were diagnosed as common, 50 of 204 (24.5%) were diag- Sex nosed as combined (BN with intradermal nevus in 84.0% Male 176 (90.7) and compound nevus in 16.0%, 2 of which were also noted Female 18 (9.3) to be mild to moderately dysplastic), and 3 of 204 (1.5%) as Age at diagnosis, mean (SD), y 62.8 (14.4) cellular. Most BN were located on the extremities (93 of 204 Pathologic diagnosis [45.6%]), followed by the head and neck (64 of 204 [31.3%]), Common 151 (74.0) and the back (35 of 204 [17.2%]). Of the 15 BN on the hands, Cellular 3 (1.5) 8 (53.3%) were on the dorsal surface, while only 2 of 9 BN on Combined 50 (24.5) the feet (22.2%) were located dorsally. For the 64 head and Body site neck BN, 33 (51.6%) were located on the scalp, 16 (25.0%) on Scalp 33 (16.2) the forehead-temple-eyebrow-eyelid region, 6 (9.4%) on the Posterior auricular region 1 (0.5) preauricular-cheek region, 3 (4.7%) on the ear, 2 (3.1%) in Forehead-temple-eyebrow-eyelid region 16 (7.8) the oral mucosa, 2 (3.1%) on the neck, and 1 each (1.6%) on Mucosal, conjunctiva 1 (0.5) the posterior auricular region and conjunctival mucosa. Cel- Preauricular-cheek region 6 (2.9) lular blue nevi were located on the scalp, upper back, and Ear 3 (1.5) dorsal hand. Mucosal, oral 2 (1.0) Clinical and histologic features are summarized in Table 1 Neck 2 (1.0) and representative histopathologic images are shown in the Arm 58 (28.4) Figure. Hand 15 (7.4) The estimated duration of the BN prior to biopsy diagno- sis was based on patient-reported onset of the lesion. Clinical Back 35 (17.2) duration was available for 65 BN in 62 patients, of whom 56 Chest 7 (3.4) (who had a mean [SD] age of 57.8 [15.9] years) reported acquir- Trunk 5 (2.5) ing the nevus 10 years or less prior to diagnostic biopsy. Nine Leg 11 (5.4) patients reported the lesion as being of “new” onset. Only 10 Foot 9 (4.4) patients reported a recent change in size or symptoms of the Figure. Representative Hematoxylin-Eosin–Stained Histopathologic Features A B A, Blue nevus, sclerotic type with dendritic melanocytes interspersed in dense collagen. B, Combined nevus with nevocellular intradermal nevus and dendritic melanocytes (original magnification ×10 for both). 874 JAMA Dermatology August 2014 Volume 150, Number 8 jamadermatology.com Copyright 2014 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/28/2021 Acquired Blue Nevi in Older Individuals Case Report/Case Series Research Table 2. Clinical and Histopathological Characteristics of 18 Melanoma in 16 Patients Diagnosed as Having Blue Nevi Patient No./ Blue Nevi Melanoma Breslow Depth, Timing of Melanoma Sex/Age, y Location Location mm Diagnosis, y 1/M/76 Trunk Nose 3.70 After, 10 2/M/50 Oral mucosa Back 0.79 After, 8 3/M/74 Right mid back Upper back 0.76 Before, 2 4/M/49 Left shoulder Left arm 1.90 Before, 3 5/M/75 Chest Trunk 0.30 Before, 0.5 6/M/76 Left arm Right forearm 0.25 Before, 3 7/M/74 Leg Chest MIS Same time 8/M/65 Temple Chest 0.60 Same time 9/M/79 Left side of back Left lower back 0.95 Before, 1 10/M/82 Back Arm MIS Same time 11/M/63 Mid back 1. Left lower back 1. MIS Before, 0.5 for both 2. Right cheek 2. 0.70 12/M/63 Scalp Back 0.45 Before, 9 13/M/79 Chest Arm MIS Before, 3 14/M/89 Back Neck MIS Before, 2 15/M/76 Left side of back 1. Left upper back 1. MIS Before, 1 for both 2.